Details for Patent: 6,197,341

✉ Email this page to a colleague

Summary for Patent: 6,197,341

Patent landscape, scope, and claims:

Title:	Formulations of balsalazide and its derivatives
Abstract:	The invention provides a unit formulation which comprises a 2-hydroxy-5-phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm.sup.3 and its use in the treatment of gastrointestinal diseases.
Inventor(s):	Friess; Stefan (S-22587 Hamburg, DE), Heckenmuller; Harald (D-22559 Hamburg, DE), Szambien; Oliver (D-23611 Bad Schwartau, DE)
Assignee:
Application Number:	09/068,823
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,197,341
Patent Claim Types: see list of patent claims	Formulation; Compound; Composition; Dosage form; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 6,197,341

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,197,341

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9700934-4	Mar 14, 1997

International Family Members for US Patent 6,197,341

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	6430198	⤷ Subscribe
Belgium	1011837	⤷ Subscribe
Brazil	9808140	⤷ Subscribe
Canada	2283297	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.